484 related articles for article (PubMed ID: 26601661)
1. Antifungal activity and mode of action of thymol and its synergism with nystatin against Candida species involved with infections in the oral cavity: an in vitro study.
de Castro RD; de Souza TM; Bezerra LM; Ferreira GL; Costa EM; Cavalcanti AL
BMC Complement Altern Med; 2015 Nov; 15():417. PubMed ID: 26601661
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effect of thymoquinone and nystatin in the treatment of oral candidiasis; an in vitro study.
Özdal Zincir Ö; Özdal U; Ünlü Ö; Demirci M; Katiboğlu AB; Egil E; Altan Şallı G
Odontology; 2022 Apr; 110(2):330-337. PubMed ID: 34657217
[TBL] [Abstract][Full Text] [Related]
3. Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis.
Jafri H; Ahmad I
J Mycol Med; 2020 Apr; 30(1):100911. PubMed ID: 32008964
[TBL] [Abstract][Full Text] [Related]
4. The in vitro post-antifungal effect of nystatin on Candida species of oral origin.
Ellepola AN; Samaranayake LP
J Oral Pathol Med; 1999 Mar; 28(3):112-6. PubMed ID: 10069538
[TBL] [Abstract][Full Text] [Related]
5. Antifungal Activity of Capric Acid, Nystatin, and Fluconazole and Their
Khalandi H; Masoori L; Farahyar S; Delbandi AA; Raiesi O; Farzanegan A; Khalandi G; Mahmoudi S; Erfanirad T; Falahati M
Assay Drug Dev Technol; 2020; 18(4):195-201. PubMed ID: 32392426
[TBL] [Abstract][Full Text] [Related]
6. Synergistic anticandidal activity of menthol in combination with itraconazole and nystatin against clinical Candida glabrata and Candida krusei isolates.
Sharifzadeh A; Khosravi AR; Shokri H; Tari PS
Microb Pathog; 2017 Jun; 107():390-396. PubMed ID: 28431915
[TBL] [Abstract][Full Text] [Related]
7. Potential effect of 2-isopropyl-5-methylphenol (thymol) alone and in combination with fluconazole against clinical isolates of Candida albicans, C. glabrata and C. krusei.
Sharifzadeh A; Khosravi AR; Shokri H; Shirzadi H
J Mycol Med; 2018 Jun; 28(2):294-299. PubMed ID: 29661606
[TBL] [Abstract][Full Text] [Related]
8. Antifungal activity of linalool in cases of Candida spp. isolated from individuals with oral candidiasis.
Dias IJ; Trajano ERIS; Castro RD; Ferreira GLS; Medeiros HCM; Gomes DQC
Braz J Biol; 2018 May; 78(2):368-374. PubMed ID: 28977047
[TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents.
Choukri F; Benderdouche M; Sednaoui P
J Mycol Med; 2014 Dec; 24(4):303-7. PubMed ID: 25442913
[TBL] [Abstract][Full Text] [Related]
10. Antifungal activity, mode of action and anti-biofilm effects of Laurus nobilis Linnaeus essential oil against Candida spp.
Peixoto LR; Rosalen PL; Ferreira GL; Freires IA; de Carvalho FG; Castellano LR; de Castro RD
Arch Oral Biol; 2017 Jan; 73():179-185. PubMed ID: 27771586
[TBL] [Abstract][Full Text] [Related]
11. [Susceptibility to nystatin of oral Candida isolates and its correlation with the response to treatment].
Santa Anna LM; Díaz Suárez LA; Illnait Zaragozí MT; Perurena Lancha MR; Cantelar de Francisco N; Fernández Andreu CM; Martínez Machín G
Rev Cubana Med Trop; 2010; 62(3):237-44. PubMed ID: 23437555
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of antifungal activity of standardized extract of Salvia rhytidea Benth. (Lamiaceae) against various Candida isolates.
Salari S; Bakhshi T; Sharififar F; Naseri A; Ghasemi Nejad Almani P
J Mycol Med; 2016 Dec; 26(4):323-330. PubMed ID: 27499461
[TBL] [Abstract][Full Text] [Related]
13. In vitro antifungal sensitivity of fluconazole, clotrimazole and nystatin against vaginal candidiasis in females of childbearing age.
Khan F; Baqai R
J Ayub Med Coll Abbottabad; 2010; 22(4):197-200. PubMed ID: 22455297
[TBL] [Abstract][Full Text] [Related]
14. The newly synthesized thiazole derivatives as potential antifungal compounds against Candida albicans.
Biernasiuk A; Berecka-Rycerz A; Gumieniczek A; Malm M; Łączkowski KZ; Szymańska J; Malm A
Appl Microbiol Biotechnol; 2021 Aug; 105(16-17):6355-6367. PubMed ID: 34410437
[TBL] [Abstract][Full Text] [Related]
15. Interactions between Terpinen-4-ol and Nystatin on biofilm of Candida albicans and Candida tropicalis.
Tonon CC; Francisconi RS; Bordini EAF; Huacho PMM; Sardi JCO; Spolidorio DMP
Braz Dent J; 2018; 29(4):359-367. PubMed ID: 30462762
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibility of oral Candida to seven antifungal agents.
Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
[TBL] [Abstract][Full Text] [Related]
17. Antifungal activity of miconazole against recent Candida strains.
Isham N; Ghannoum MA
Mycoses; 2010 Sep; 53(5):434-7. PubMed ID: 19531099
[TBL] [Abstract][Full Text] [Related]
18. The comparative study of antifungal activity of Syzygium aromaticum, Punica granatum and nystatin on Candida albicans; an in vitro study.
Mansourian A; Boojarpour N; Ashnagar S; Momen Beitollahi J; Shamshiri AR
J Mycol Med; 2014 Dec; 24(4):e163-8. PubMed ID: 25442923
[TBL] [Abstract][Full Text] [Related]
19. In vitro antifungal resistance profile of Candida strains isolated from Saudi women suffering from vulvovaginitis.
Yassin MT; Mostafa AA; Al-Askar AA; Bdeer R
Eur J Med Res; 2020 Jan; 25(1):1. PubMed ID: 31901238
[TBL] [Abstract][Full Text] [Related]
20. Antifungal activity of Punicalagin-nystatin combinations against Candida albicans.
da Silva RA; Ishikiriama BLC; Ribeiro Lopes MM; de Castro RD; Garcia CR; Porto VC; Santos CF; Neppelenbroek KH; Lara VS
Oral Dis; 2020 Nov; 26(8):1810-1819. PubMed ID: 32583467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
